Cases & Deals

Idenix asserts patent infringement against Gilead in Australia related to Sovaldi® and Harvoni®

Clients Idenix Pharmaceuticals LLC

Jones Day represents Idenix Pharmaceuticals LLC (a subsidiary of Merck & Co., Inc.) in patent litigation against Gilead in the Federal Court of Australia over sofosbuvir, the active ingredient in Sovaldi® and Harvoni®, Gilead's blockbuster drugs for treating Hepatitis C. Subject matter is nucleoside analogs and prodrugs for treating Flaviviridae infections, including HCV.

Gilead Sciences Pty Ltd v. Idenix Pharmaceuticals Inc & Ors, No NSD 48/2013 (Federal Court of Australia, January 17, 2013)